Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FZH78
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,415.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,415.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Mirena 52 mg contraceptive systems. The contract, which carries no set-aside designation, was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion framework awarded on November 13, 2025, designed to support the Department of Defense's global pharmaceutical supply needs through December 31, 2036.
DMS Pharmaceutical Group Inc. has established itself as a critical supplier within the federal pharmaceutical supply chain, demonstrating substantial contracting activity with the Defense Logistics Agency's Medical Supply Chain division. The company's comprehensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill diverse pharmaceutical requirements for military healthcare facilities worldwide. Under the broader PPV-G GEN V acquisition strategy, valued at $30.3 billion, DMS Pharmaceutical Group serves as a regional prime vendor contractor authorized to provide firm fixed-price delivery orders for recurring medical supply needs across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB26FZH78?
SPE2DB26FZH78 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FZH78 worth?
The government has obligated $10,415 on SPE2DB26FZH78.
Is contract SPE2DB26FZH78 an order under another contract?
Yes. SPE2DB26FZH78 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB26FZH78 competed?
The extent of competition for SPE2DB26FZH78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award